The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search feed instagram google-plus avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content

Every day, pharmaceutical companies produce new drugs to treat medical problems, but despite FDA approval, these drugs are not always safe. After using Elmiron, which is the only drug that the FDA has approved to treat a painful bladder condition called interstitial cystitis, patients increasingly have developed maculopathy, which affects their vision.

Researchers have found that some patients who have taken Elmiron experience pigmentary maculopathy, which impacts the macula, or the central part of the retina.

Pigmentary maculopathy can have devastating effects on the individuals who have developed the condition after taking Elmiron. Individuals may no longer be able to work and engage in activities that they enjoyed, such as reading or sports activities. This condition also may cause pain in some cases, which can contribute to a loss of quality of life. Other consequences include:

  • Retinal Maculopathy
  • Blurred Vision
  • Blindness (unilateral or bilateral)
  • Vision Loss/Vision Impairment
  • Visual disturbances

You trust the medicine that your doctors prescribe to heal or alleviate the symptoms of various medical conditions. However, you do not expect for that medicine to cause you new medical problems.  If you or a loved one has suffered these debilitating side effects from taking Elmiron, you may wish to contact a lawyer to evaluate any potential claims you may have.

Comments for this article are closed, but you may still contact the author privately.